Be Aware of SGLT2 Inhibitor Risks

May 2020

SGLT2 inhibitor (Jardiance, etc) risks will be back in the spotlight...due to recent label changes.

These meds are getting more use now that most have proven CV benefits...despite usually costing about $500/month.

Be familiar with how to manage SGLT2 inhibitor risks.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote